Active placebos versus antidepressants for depression-Reference-Cited by-同舟云学术

Active placebos versus antidepressants for depression

Published:2004-01-26 Issue:10 Volume:2012 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Moncrieff Joanna¹,Wessely Simon²,Hardy Rebecca³

Affiliation:

1. University College London; Mental Health Sciences; Charles Bell House 57-73 Riding House Street London UK WiW 7EJ

2. Guy's, King's & St Thomas School of Medicine & Institute of Psychiatry; Academic Dept of Psychological Medicine; 103 Denmark Hill London UK SE5 8AF

3. MRC National Survey of Health and Development; Department of Epidemiology and Public Health; 33 Bedford Place London UK WC1B 5JU

Publisher

Wiley

Subject

Pharmacology (medical)

Reference54 articles.

1. Imipramine in office management of depressive reactions;Daneman;Diseases of the Nervous System,1961

2. Imipramine (tofranil) vs. placebo in hospitalised psychotic depressives;Friedman;Journal of Psychiatric Research,1966

3. Interaction of drug therapy with marital therapy in depressive patients;Friedman;Archives of General Psychiatry,1975

4. Controlled comparison of imipramine, amitriptyline and placebo in hospitalised depressed patients;Hollister;Journal of Nervous and Mental Disease,1964

5. Drugs in depressive illness;Hussain;BMJ,1970

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psychostimulant Augmentation of Antidepressant Therapy in Depression: a Systematic Review and Meta-Analysis;Current Treatment Options in Psychiatry;2023-11-18

2. The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression;Frontiers in Psychiatry;2023-09-19

3. The role of the communicated treatment rationale on treatment outcome: study protocol for a randomized controlled trial;Trials;2023-08-17

4. No benefit of antidepressants in inpatient treatment of depression. A longitudinal, quasi-experimental field study;Psychopharmacology;2023-08-01

5. Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review;Journal of Psychopharmacology;2023-07